REL logo

RELX PLC Stock Price

LSE:REL Community·UK£55.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 72 Fair Values set on narratives written by author

REL Share Price Performance

UK£30.25
-6.06 (-16.69%)
UK£44.18
Fair Value
UK£30.25
-6.06 (-16.69%)
31.5% undervalued intrinsic discount
UK£44.18
Fair Value
Price UK£30.25
AnalystConsensusTarget UK£44.18

REL Community Narratives

AnalystConsensusTarget·
Fair Value UK£44.18 31.5% undervalued intrinsic discount

Analysts Highlight Mixed Outlook for RELX as Valuation and Profit Estimates Rise

2users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
UK£44.18
31.5% undervalued intrinsic discount
Revenue
6.46% p.a.
Profit Margin
23.45%
Future PE
35.88x
Price in 2028
UK£54.97

Trending Discussion

Updated Narratives

REL logo

REL: Generative AI Will Drive Legal Market Gains Despite Increased Competition

Fair Value: UK£44.18 31.5% undervalued intrinsic discount
42 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Established dividend payer and good value.

1 Risk
5 Rewards

RELX PLC Key Details

UK£9.5b

Revenue

UK£3.3b

Cost of Revenue

UK£6.2b

Gross Profit

UK£4.3b

Other Expenses

UK£1.9b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 12, 2026
1.06
65.48%
20.19%
339.2%
View Full Analysis

About REL

Founded
1903
Employees
36000
CEO
Erik Engstrom
WebsiteView website
www.relx.com

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Recent REL News & Updates

Are Investors Undervaluing RELX PLC (LON:REL) By 28%?

Nov 27
Are Investors Undervaluing RELX PLC (LON:REL) By 28%?

Recent updates

No updates